• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
april@madhedgefundtrader.com

About april@madhedgefundtrader.com

This author has not written his bio yet.
But we are proud to say that april@madhedgefundtrader.com contributed 2252 entries already.

Entries by april@madhedgefundtrader.com

Diary, Newsletter, Research

How My Mad Hedge AI Market Timing Algorithm Works

Since we have just taken in a large number of new subscribers from around the world, I will go through the basics of my Mad Hedge AI Market Timing Index one more time. I have tried to make this as easy to use as possible, even devoid of the thought process. When the index is

Biotech Letter

December 26, 2024

Mad Hedge Biotech and Healthcare Letter December 26, 2024 Fiat Lux   Featured Trade: (PHASE 2 OR NOT PHASE 2: THAT'S NOT EVEN A QUESTION IN 2025) (LLY), (NVO)

Biotech Letter

Phase 2 Or Not Phase 2: That's Not Even A Question In 2025

I had dinner with a veteran biotech investor at San Francisco's Waterbar earlier this month, watching the Bay Bridge lights while discussing what's coming for biotech in 2025. "The game is changing," he said, picking at his salmon. "It's not about platform promises anymore. Show me the Phase 2 data, or don't show up at

Diary, Newsletter, Summary

December 26, 2024

Global Market Comments December 26, 2024 Fiat Lux   SPECIAL ISSUE ABOUT THE FAR FUTURE Featured Trade: (PEAKING INTO THE FUTURE WITH RAY KURZWEIL), (GOOG), (INTC), (AAPL), (TXN)

Biotech Letter

December 24, 2024

Mad Hedge Biotech and Healthcare Letter December 24, 2024 Fiat Lux   Featured Trade: (THE LAB RESULTS ARE IN) (GILD), (TSLA), (WVE), (EDIT), (CRSP), (LLY), (NVO), (WMT), (CVS), (CCCC), (RHHBY)

Biotech Letter

The Lab Results Are In

I found myself gridlocked in Bay Area traffic a few days ago, inching past Gilead's (GILD) sprawling Foster City headquarters, when my phone lit up with a call from an old friend at Goldman. “Alright, tell me—what’s the real story with biotech this year?” she asked, her tone hovering somewhere between curiosity and exasperation. “Half

Diary, Newsletter, Summary

December 24, 2024

Global Market Comments December 24, 2024 Fiat Lux   Featured Trade: (THE NEXT COMMODITY SUPER CYCLE HAS ALREADY STARTED), (COPX), (GLD), (FCX), (BHP), (RIO), (SIL), (PPLT), (PALL), (GOLD), (ECH), (EWZ), (IDX)

Diary, Newsletter

The Next Commodity Super Cycle Has Just Began

When I closed out my position in Freeport McMoRan (FCX) near its max profit earlier this year, I received a hurried email from a reader if he should still keep the stock. I replied very quickly: “Hell, yes!” When I toured Australia a couple of years ago, I couldn’t help but notice a surprising number

Tech Letter

December 23, 2024

Mad Hedge Technology Letter December 23, 2024 Fiat Lux   Featured Trade: (THE FUTURE IS HERE) (NO CODE)

Tech Letter

The Future Is Here

The future is here. No code or low code will bring a raft of new innovative tech companies to market, and we are in the early innings of this transformative development. What is no code? No-code is an approach to designing and using applications that requires zero coding or knowledge of programming languages. This type

Page 39 of 211«‹3738394041›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top